Home » Topics » Disease categories and therapies » Immune

Immune
RSS

MOMP DNA immunization for chlamydial infections

Oct. 6, 1997

OraVax to market and distribute Evans Medical's yellow fever vaccine

Oct. 3, 1997

North American Vaccine advances with meningitis B vaccine

Oct. 2, 1997

Collaborators demonstrate protection against HSV with Cel-Sci vaccine

Oct. 1, 1997

LF-08-0299 both prevents and reverses kidney rejection in dogs

Sep. 30, 1997

FTY-720: novel immunosuppressant for combination therapy

Sep. 25, 1997

Twinrix approved for marketing in Canada

Sep. 25, 1997

NABI introduces new formulation of WinRho SDF

Sep. 23, 1997

CD45RB antibody available for licensing from RCT

Sep. 17, 1997

Thailand grants first approval for WF-10

Sep. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...